1981

Tom Templeman ’81 has joined Medivation as senior vice president of pharmaceutical operations. With more than 25 years of pharmaceutical experience, Dr. Templeman previously served as vice president of manufacturing, science, and technology at Hospira; as senior vice president, integrated supply chain at Liquidia Technologies; and in various leadership roles at Johnson & Johnson, where he worked for 13 years in a number of capacities, most recent as general manager of Centocor Biologics, LLC and head of the global biologics supply chain. 

Medivation, Inc. is a biopharmaceutical company focused on the development and commercialization of medically innovative therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families.

 

29 Oct 2018